Mission
Bioethics International (BEI) is dedicated to advancing patient and global health by ensuring that pharmaceutical innovation is responsible and patient-centered. The organization works to develop, monitor, and disseminate industry benchmarks for ethics, equity, and social responsibility in healthcare, involving stakeholders such as physicians, patients, and regulators.
Basic Information
Founded in
2006
EIN
87-0774767
Total Assets
$740.7 thousand
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
At a Glance
Good Pharma Scorecard
The Good Pharma Scorecard ranks pharmaceutical and biotechnology companies on their bioethics and social responsibility performance, focusing on patient-centric issues that affect public health.
2024 Roundtable: Bioethics, Patient Centricity + Health Equity in Pharma
Join us in June 2024 for a comprehensive discussion on metrics for success in patient-centric bioethics and health equity in the pharmaceutical sector.
Annual Patient Roundtable
An annual discussion where patients and healthcare professionals share insights on bioethics and responsibilities in the pharmaceutical industry.
Past Events
Roundtable: Bioethics, Social Responsibility + Health Equity in Pharma
September 15, 2023
This year’s roundtable focuses on metrics + strategies for advancing bioethics, patient-centricity + health equity across the bio-pharmaceutical sector.
National Health Council, 2022 Science of Patient Engagement Symposium
October 19, 2022 — October 20, 2022
Keynote at the National Health Council's symposium discussing health equity and patient engagement.
2023 Trialscope Disclose Conference
July 17, 2023
An annual gathering featuring insights from industry leaders on best practices for clinical trial transparency.
Upcoming Events
2024 Roundtable: Bioethics, Patient Centricity + Health Equity in Pharma
June 24, 2024
Join us in June 2024 for a comprehensive discussion on metrics for success in patient-centric bioethics and health equity in the pharmaceutical sector.
Learn MoreImpact Reports
Metrics, baseline scores, and a tool to improve sponsor performance on clinical trial diversity: retrospective cross sectional study
Evaluation of Drug Trials in High, Middle, and Low-Income Countries and Local Commercial Availability of Approved Drugs
Ethical considerations in international clinical trial site selection
MIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
49
30
/100
Program Expense Ratio
87.26%
18
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.6055
6
/20
Working Capital Ratio
265.9
2
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 0 | 0.00% |
| Program Services | 0 | 0.00% |
| Investment Income | 0 | 0.00% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 0 | 100.00% |
Related Nonprofits
Scientific Workshops A New Jersey Nonprofit Corporation
Science & Tech
Science & Tech Society
Ampp Global Center Inc.
Science & Tech
Science & Tech SocietyCivil and Environmental Engineering Visiting Council Inc.
Science & Tech
Science & Tech SocietyCouncil on Technology & Society
Science & Tech
Science & Tech SocietyExperimental Aircraft Association Inc.
Science & Tech
Science & Tech Society